StockGlow

Intellia Therapeutics, Inc. (38I.F)

Intellia Therapeutics, Inc.

9.16+0.01%Healthcare
Compare 38I.F with
StockGlow Score
9
Bearish
BearishBullish
1 year ago-6.1%

The outlook

Intellia Therapeutics, Inc. currently reads as bearish based on below its 50- & 200-day averages, 14% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range14% of the way from its 52-week low to high
Market cap
$1.28B
52-wk high
24.34
52-wk low
6.75
50-day avg
12.07
200-day avg
10.75
Trailing P/E
—

Similar stocks

8EM.FEditas Medicine, Inc.$2.24+0.00%2L9.FVisionWave Holdings, Inc.$1.70-10.55%UP0.FUltragenyx Pharmaceutical Inc.$21.47-4.54%AB3A.FSarepta Therapeutics, Inc.$13.50+1.50%4DN.FDenali Therapeutics Inc.$20.72-0.86%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy